Thyroid Cancer Surgery
On this page
Direct answer
How much thyroid to remove depends on cancer risk: hemithyroidectomy (lobectomy plus isthmus) suffices for low-risk unifocal papillary cancers up to 4 cm without extrathyroidal extension or nodal disease (and for follicular neoplasms awaiting histology), while total thyroidectomy is indicated for tumours over 4 cm, gross extrathyroidal extension, clinically apparent nodal or distant metastases, bilateral or multifocal disease, aggressive histologies, age over 55 years, prior neck irradiation or familial disease — and is a prerequisite when radioactive iodine ablation or thyroglobulin follow-up is planned. Technique protects two structures: the recurrent laryngeal nerve, identified routinely (visualisation, with intraoperative nerve monitoring as an adjunct) before ligating the inferior thyroid artery branches, and the parathyroids, preserved on their vascular pedicles with autotransplantation of any devascularised gland into sternomastoid or forearm. Post-thyroidectomy care monitors voice and calcium; radioiodine ablation after total thyroidectomy is given to intermediate and high-risk differentiated cancers, with TSH-suppressive levothyroxine tailored to risk.
What you must remember
- Extent-of-surgery rules (per ATA-style guidance): hemithyroidectomy for intrathyroidal papillary microcarcinomas and low-risk tumours up to 4 cm; total thyroidectomy for over 4 cm, extrathyroidal extension (T3 and beyond), clinical nodal involvement (N1a/b), distant metastases, bilateral or multifocal disease, history of radiation, familial syndromes, and age 55 or older.
- Completion thyroidectomy: an incidental cancer found after lobectomy for a "benign" nodule is converted to total when the above criteria apply — timing within days (before fibrosis) or after 8–12 weeks, and total thyroidectomy enables I-131 ablation and serum thyroglobulin surveillance.
- Histology-driven operations: papillary — nodal spread dictates concurrent central compartment dissection when nodes are clinically involved; follicular and Hürthle cell — hemodynamic spread, hemithyroidectomy for a follicular neoplasm of uncertain behaviour (minimally invasive versus widely invasive on capsular/vascular invasion); medullary — total thyroidectomy with routine central neck dissection (and lateral if nodes positive), RET testing and calcitonin follow-up; anaplastic — usually biopsy (core) and multimodality palliation, tracheostomy only for threatened airway after discussion.
- RLN care: identify the nerve along the entire course before division of ligatures — external branch of superior laryngeal nerve preserved by ligating superior pole vessels close to the gland; intraoperative nerve monitoring is an adjunct, not a substitute; bilateral injury presents as stridor and airway compromise at extubation (emergency reintubation or tracheostomy).
- Parathyroid care: identify all four glands when safe; keep them with intact blood supply (ligate inferior artery branches distally); a devascularised gland is confirmed frozen-section and autotransplanted into muscle (30–40 mg slices); permanent hypoparathyroidism is defined beyond 6 months — transient hypocalcaemia is common after total thyroidectomy.
- Radioactive iodine: remnant ablation or adjuvant therapy for intermediate/high-risk differentiated cancer (and selected low-risk with aggressive histology), using recombinant TSH stimulation or thyroid hormone withdrawal, with post-treatment scanning; not used in medullary or anaplastic disease.
- Follow-up framework: risk-adapted (ATA low/intermediate/high) response-to-therapy categories — suppressed and stimulated thyroglobulin, neck ultrasound — with TSH targets around 0.5–2 mIU/L low risk and below 0.1 high risk; low-risk papillary cancer carries 10-year survival well above 90 per cent.
- Practical adjuncts: preoperative laryngoscopy for any hoarseness or before reoperative surgery; drains for large goitres and lateral neck dissections; sternotomy threatened only by large retrosternal extension.
A typical case walked through
A 38-year-old woman has a 3.5 cm right thyroid nodule; TSH is normal, ultrasound shows a suspicious solid nodule with ipsilateral lateral node, and cytology is Bethesda VI (papillary carcinoma). Plan the operation: because there is clinical N1b disease, total thyroidectomy is indicated despite the tumour being under 4 cm; the lateral neck adds a modified radical dissection of levels II–V (jugular chain nodes). In theatre, both recurrent laryngeal nerves are identified and preserved, parathyroids are safeguarded — one devascularised right inferior gland is autotransplanted into sternomastoid — and the central compartment (level VI) is dissected with the specimen since the level is at risk even when uninvolved clinically. Postoperatively: voice assessment, calcium (and phosphate) monitoring, calcium and calcitriol supplementation for transient hypoparathyroidism; pathology returns a 3.5 cm papillary carcinoma, unifocal, minimal extrathyroidal extension, 3 of 12 nodes positive (N1b) — ATA intermediate risk. She receives recombinant-TSH-stimulated I-131 ablation, then levothyroxine with TSH held mildly suppressed, and enters thyroglobulin-plus-ultrasound surveillance. Contrast the forks: a 1.2 cm intrathyroidal papillary microcarcinoma in a 29-year-old with negative ultrasound nodes could be treated by hemithyroidectomy alone, no iodine, mild TSH target; a 6 cm follicular lesion gets a diagnostic lobectomy converted to completion thyroidectomy if histology shows widely invasive follicular carcinoma.
Where students slip
First, extent-of-surgery extremes — answering "total thyroidectomy for all cancers" ignores the legitimate hemithyroidectomy for low-risk disease (an increasingly exam-relevant nuance), while under-calling total thyroidectomy in N1 or over-4 cm disease loses the easy mark. Second, the parathyroids: answers that never mention autotransplantation or the 6-month definition of permanent hypoparathyroidism miss the physiology the examiner probes. Third, medullary carcinoma — forgetting routine central dissection and RET testing (and phaeochromocytoma exclusion in MEN2 before operating) is the classic viva trap.
Frequently asked questions
When is hemithyroidectomy adequate for thyroid cancer?
For unifocal, intrathyroidal papillary carcinoma up to 4 cm with no extrathyroidal extension, no nodal or distant disease and no high-risk features — with the caveat that total thyroidectomy is chosen when radioiodine or thyroglobulin surveillance is desired.
Which two structures dictate thyroidectomy technique?
The recurrent laryngeal nerve (routinely identified; bilateral injury causes stridor and airway obstruction) and the parathyroid glands (preserved with their blood supply; devascularised glands are autotransplanted).
Why does medullary carcinoma get total thyroidectomy with central neck dissection?
It spreads early to central (level VI) nodes and does not take up radioiodine, so surgery is the sole curative modality — plus RET mutation testing and calcitonin-based follow-up.
When is radioactive iodine given after total thyroidectomy?
For intermediate and high-risk differentiated (papillary/follicular) cancer as remnant ablation or adjuvant therapy — not for medullary or anaplastic tumours.
How is permanent hypoparathyroidism defined and minimised?
Calcium requirements persisting beyond 6 months postoperatively; minimised by meticulous parathyroid identification, distal ligation of inferior thyroid artery branches, and autotransplantation of devascularised glands.